INCREASED EXPRESSION OF SURFACE IGM BUT NOT IGD OR IGG ON HUMAN B-CELLS IN RESPONSE TO IL-4
- 1 February 1989
- journal article
- research article
- Vol. 66 (2) , 224-227
Abstract
Surface IgM (sIgM) was increased up to 10 times on human tonsillar B cells activated with IL-4. No change was observed for surface IgD, IgG or IgE. Other activators of human B cells, such as TPA, EBV and anti-IgM resulted in increased expression of the low-affinity receptor for IgE (CD23), but had no effect on sIgM. IL-4 also increased sIgM expression on prolymphocytic leukaemic (PLL) B cells whereas TPA significantly reduced the level of sIgM. The effect on sIgM thus seems specific for IL-4, and is consistent with the existence of a unique IL-4-dependent B-cell activation pathway. Preincubation with IL-4 did not ''prime'' B cells to proliferate in response to subsequent exposure to anti-IgM, and slightly decreased the response to co-stimulation with IL-4 and anti-IgM. The increase in sIgM expression in response to IL-4, therefore, does not seem to be important for proliferation.This publication has 14 references indexed in Scilit:
- Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.The Journal of Immunology, 1988
- Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)European Journal of Immunology, 1988
- B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.The Journal of Immunology, 1987
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.The Journal of Experimental Medicine, 1987
- Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.The Journal of Experimental Medicine, 1987
- CONTROL OF HUMAN LYMPHOCYTE-B REPLICATION .1. CHARACTERIZATION OF NOVEL ACTIVATION STATES THAT PRECEDE THE ENTRY OF G0 B-CELLS INTO CYCLE1986
- B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.The Journal of Experimental Medicine, 1986
- Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.Proceedings of the National Academy of Sciences, 1984
- The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications.The Journal of Immunology, 1980
- An improved rosetting assay for detection of human T lymphocytesJournal of Immunological Methods, 1974